FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs ...Middle East

The Hill - News
FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs
The Food and Drug Administration (FDA) is looking into reports of adverse side effects from using diabetes medications such as Ozempic and Mounjaro, with hair loss, suicidal thoughts and airway obstruction being among the reported complications. According to the latest information from the agency, the FDA Adverse Event Reporting System (FAERS) received reports of patients experiencing alopecia, aspiration and suicidal ideation while taking glucagon-like peptide-1 (GLP-1) receptor agonists. The agency is "evaluating the need for regulatory action." GLP-1 receptor agonists like Ozempic, Mounjaro, Wegovy and Zepbound work by mimicking the hormone known as GLP-1. This hormone stimula

Hence then, the article about fda investigates reports of hair loss suicidal thoughts in people using popular diabetes weight loss drugs was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs )

Apple Storegoogle play

Last updated :

Also on site :